How much does Techdow Pharma England Limited make?

Techdow Pharma England Limited reported revenue of £48.8m and £871k profit in the year to 31 Dec 2025, according to its accounts filed at Companies House.

How many employees does Techdow Pharma England Limited have?

Techdow Pharma England Limited reported an average of 12 employees in the year to 31 Dec 2025.

Is Techdow Pharma England Limited profitable?

Yes — Techdow Pharma England Limited reported a profit of £871k in the year to 31 Dec 2025.

Company No. 10513412 · Incorporated 6 Dec 2016

Techdow Pharma England Limited

Registered name: TECHDOW PHARMA ENGLAND LIMITED

Techdow Pharma England Limited made £48.8m revenue and £871k profit in the year to 31 Dec 2025.

Techdow Pharma England Limited’s revenue grew 23% to £48.8m in the year to 31 Dec 2025, with £871k profit and 12 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Guildford; we hold 5 years of its filed accounts.

Full P&L filedSection G · Wholesale and retail trade; repair of motor vehiclesSIC 46460Wholesale of pharmaceutical goods

Status: Active
Location: Guildford, South East
Age: 9 yrs · since 2016
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “TD Pharma B.V.”

Latest accounts · year to 31 Dec 2025

Key figures

Cash flow filed

Revenue

£48.8m

Growth ▲22.9%

Profit

£871k

Growth ▲19.2%

Profit margin

1.8%

Gross 27.5%

Employees

Change ▲9.1%

Profit / employee

£72.5k

Revenue/employee £4.1m

Profitable streak

4yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

5 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2021	31 Dec 2022	31 Dec 2023	31 Dec 2024	31 Dec 2025
Disclosure	Full P&L	Full P&L	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£31.7m	£42.8m	£49.9m	£39.7m	£48.8m
Cost of sales	£29.9m	£29.6m	£31.5m	£26.9m	£35.4m
Gross profit	£1.8m	£13.2m	£18.4m	£12.7m	£13.4m
Operating profit	−£6.6m	£5.5m	£4.7m	£1m	£1.1m
Profit before tax	−£6.6m	£5.5m	£4.7m	£975k	£1.2m
Profit after tax	−£6.6m	£5.4m	£5.6m	£730k	£871k
Profit (best available)	−£6.6m	£5.4m	£5.6m	£730k	£871k
Staff costs	£691k	£1.1m	£1.1m	£1.6m	£1.6m
Employees (average)	8	8	8	11	12
Ratios
Profit margin	−20.9%	12.7%	11.2%	1.8%	1.8%
Gross margin	5.6%	30.9%	36.9%	32.1%	27.5%
Revenue per employee	£4m	£5.4m	£6.2m	£3.6m	£4.1m
Profit per employee	−£828k	£680k	£701k	£66.4k	£72.5k
Cash conversion	—	19.7%	77.8%	−438.3%	−245.4%
Growth (year on year)
Revenue growth	—	▲35.3%	▲16.5%	▼20.5%	▲22.9%
Profit growth	—	—	▲3.1%	▼87%	▲19.2%
Headcount growth	—	0%	0%	▲37.5%	▲9.1%
Balance sheet — indirect signals, not revenue
Cash at bank	£9.2m	£10.3m	£13.9m	£9.5m	£6.8m
Net assets	−£13.7m	−£8.3m	−£2.7m	−£2m	−£1.1m
Current assets	£31.2m	£37.4m	£35.3m	£43.1m	£47.3m
Debtors	£9.6m	£8.1m	£8.6m	£7.4m	£10.4m
Deferred income	£7m	£7.4m	£9.5m	£6.8m	£6.6m
Cash from operations	£3.6m	£1.1m	£3.7m	−£4.4m	−£2.8m
Source	Accounts · bulk data Dec 2023	Accounts · bulk data Dec 2023	Accounts · bulk data Sep 2024	FullAccounts · bulk data Dec 2025	FullAccounts · bulk data Sep 2026

Derived from the latest filing

How the business works

Profit margin: 1.8%; Profit ÷ revenue.
Gross margin: 27.5%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £4.1m; Revenue ÷ average employees.
Profit per employee: £72.5k; Profit ÷ average employees.
Cash conversion: −245.4%; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 13.5%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 21.4%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: —; Now −£1.1m
Cash at bank: ▼29%; Now £6.8m
Headcount: ▲9%; Now 12
Deferred income: ▼3%; Now £6.6m
Fixed assets: —; Now —

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Minority corporate shareholders

Techdow Pharma Netherlands Bv (registered outside the UK register)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £871k), from the Companies House accounts bulk data published Sep 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.